This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aggarwal, A. Articles by Kaye, D. M. Search for Related Content PubMed PubMed Citation Articles by Aggarwal, A. Articles by Kaye, D. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure Related Collections Cardio-renal physiology/pathophysiology

(Circulation. 2002;105:1031.)
© 2002 American Heart Association, Inc.

Brief Rapid Communications

Norepinephrine Turnover Is Increased in Suprabulbar Subcortical Brain Regions and Is Related to Whole-Body Sympathetic Activity in Human Heart Failure

Anuradha Aggarwal, MBBS; Murray D. Esler, MBBS, PhD; Gavin W. Lambert, PhD; Jacqueline Hastings, PhD; Leonie Johnston, RN; David M. Kaye, MBBS, PhD

From the Baker Medical Research Institute, Melbourne, Australia.

Correspondence to Dr David M. Kaye, Baker Medical Research Institute, PO Box 6492 St Kilda Road Central, Melbourne, Victoria 8008, Australia. E-mail d.kaye{at}alfred.org.au

	Abstract

Top Abstract Introduction Methods Results Discussion Conclusions References

 
Background— Although it is established that heightened sympathetic drive exists in congestive heart failure (CHF), the reflex processes by which this may occur and the sites in the central nervous system that may be responsible for mediating this process are not yet fully elucidated.

Methods and Results— Eight patients with moderate to severe CHF and 8 healthy control subjects underwent simultaneous arterial and bilateral internal jugular venous blood sampling and cerebral venous blood pool scanning for anatomical determination of the origin of internal jugular venous blood flow. We estimated sympathetic nervous activity by measuring total body norepinephrine (NE) spillover using radiotracer methodology and determined brain NE turnover by measuring the internal jugular overflow of NE and its lipophilic metabolites, 3-methoxy-4-hydroxyphenylglycol and 3,4-dihydroxyphenylglycol. Suprabulbar subcortical turnover of NE was significantly greater in CHF patients than in the healthy group (2.77±0.75 versus 0.66±0.40 nmol/min, P<0.05). There was a significant positive correlation between suprabulbar subcortical turnover of NE and total body NE spillover (r=0.62, P=0.01).

Conclusions— This study, for the first time, demonstrates elevated suprabulbar subcortical noradrenergic activity in human CHF and identifies a positive correlation between this and the level of whole-body NE spillover. The findings suggest that the activation of noradrenergic neurons projecting rostrally from the brain stem mediates sympathetic nervous stimulation in CHF.

Key Words: heart failure • brain • nervous system, sympathetic • norepinephrine

	Introduction

Top Abstract Introduction Methods Results Discussion Conclusions References

 
High sympathetic tone has been correlated with poor outcome in heart failure.^1–3 Although the role of the sympathetic nervous system in the pathophysiology of congestive heart failure (CHF) has been established, the nature of the afferent signals and the sites of origin of the efferent signals from the central nervous system that are responsible for the heightened sympathetic tone have not been fully elucidated.

Our group previously demonstrated a positive correlation between pulmonary artery pressures and cardiac norepinephrine (NE) spillover rate in CHF patients. Further, we have shown that a positive correlation exists between brain NE turnover, a measure of central noradrenergic neuronal activity, and cardiac NE spillover rate. These 2 findings combined suggest the existence of a reflex link, consisting of afferent neural traffic from the cardiopulmonary receptors and sympathetic efferent outflow from the brain driven by sympathoexcitatory noradrenergic neurons.

In the present study, our aim was to investigate this reflex further by first attempting to locate better the sites in the central nervous system that are responsible for the efferent signals; in addition, we wished to investigate the relationship between central NE turnover and global sympathetic activity.

	Methods

Top Abstract Introduction Methods Results Discussion Conclusions References

 
Subject Characteristics
Results from studies performed on 8 CHF patients (aged 51.9±5.6 years) and 8 healthy volunteers (aged 55.3±9.5 years) form the basis for this report. The CHF group had markedly impaired left ventricular function (ejection fraction of 24.5±7.2%). The mean pulmonary capillary wedge pressure in this group was 22.7±1.8 mm Hg. All patients were on standard anti-failure therapy, which consisted of digoxin (n=8), diuretics (n=8), and an angiotensin-converting enzyme inhibitor (n=8). Five CHF patients were also on carvedilol. The healthy control subjects were recruited by advertisement in the general community. The study was performed with the approval of the Alfred Hospital Ethics Review Committee, and all the subjects gave written informed consent.

Catheterization Protocol
All studies were performed in the morning after a light breakfast. After a priming bolus of 12 µCi of 1-[ring-2,5,6-³H] NE (New England Nuclear; specific activity, 40 to 50 µCi/mmol) via a peripheral vein, an infusion was commenced at 0.7 µCi · m^-2 · min^-1 to maintain plateau plasma concentrations during the study. To ensure steady-state levels of the infusate, we waited at least 45 minutes after commencing the infusion before performing baseline blood sampling. Under local anesthesia, the radial artery was cannulated (3F, 5cm, Cook) for arterial pressure monitoring and blood sampling. Venous introducer sheaths were placed in the antecubital fossae bilaterally. In the patients with CHF, a pulmonary artery thermodilution catheter (7F, Arrow, Arrow International) was advanced under fluoroscopic control to the pulmonary circulation to measure right-sided heart pressures, pulmonary capillary wedge pressure, and cardiac output. Subsequently in these patients and the healthy control subjects, coronary sinus thermodilution catheters (Webster CCS 7/8U 90A, Webster Laboratories) were introduced bilaterally via the antecubital venous sheaths. These were manipulated into both the right and left internal jugular veins (IJV) above the confluence of the facial veins for jugular venous blood sampling and for the determination of jugular blood flow by thermodilution.^4–6 The tip of the catheter was placed beyond the mandibular angle, upstream to the point of entry of any venous tributaries from the tissues of the face to minimize contamination of the cerebral venous effluent.

Cerebral Venous Blood Flow Lateralization
Using a technetium-99 cerebral venous sinus scan to delineate the pattern of venous drainage in individual subjects, subcortical and cortical neurotransmitter turnover can be distinguished.⁴ The usual pattern is for the right IJV to have the superior sagittal sinus as its major tributary and the cerebral cortex as its predominant field of drainage. This we designate the "dominant" or "cortical" IJV. In this situation, the suprabulbar subcortical venous drainage from regions such as the hypothalamus and amygdala is into the left IJV, and we designate this the "nondominant" or "subcortical" IJV (Figure 1). Venous drainage from the medulla oblongata is primarily into the veins of the spinal cord and dural venous sinuses, not the IJVs.⁷ Sometimes the venous sinus drainage pattern is reversed, with cortical venous drainage into the left IJV. Another normal variant is that the drainage is nonlateralizing, with ready admixture of blood occurring at the confluence of the sagittal and straight sinuses. In this report, only data from subjects with cerebral venous lateralization is presented.

View larger version (55K): [in this window] [in a new window]   Figure 1. Top, Patterns of cerebral venous sinus drainage seen with SPECT technetium-99 scans. Examples of IJV flow types and their representative venous scans are shown. RD indicates right dominant (superior sagittal sinus drains to right IJV); LD, left dominant (sagittal sinus drainage to left IJV); NL, nonlateralizing (sagittal sinus drainage to both IJVs); C, cortical drainage; and SC, subcortical drainage. Bottom, Brain NE turnover. *P<0.05 for subcortical versus cortical drainage in CHF. P<0.05 for subcortical drainage in CHF patients versus healthy volunteers.

Neurochemical Measures of Sympathetic Activity
Whole-body sympathetic nervous activity was determined by the principle of isotope dilution, as previously described.⁸ Venoarterial plasma concentration differences combined with IJV flow were used, in accordance with the Fick principle, to determine metabolite spillover from the brain. The central nervous system noradrenergic turnover was estimated by summing the IJV spillover of NE, 3-methoxy-4-hydroxyphenylglycol (MHPG), and 3,4-dihydroxyphenylglycol.^4–6

Biochemical Assays
NE, dihydroxyphenylglycol, and MHPG concentrations were measured with high-performance liquid chromatography, according to previous methods.⁹ Fractions from the effluent containing tritium-labeled NE were assayed by liquid scintillation spectroscopy.

Statistical Analysis
Data are presented as mean±SEM, unless otherwise stated. Data were normally distributed, and statistical analysis was performed using Student’s t test (SigmaStat version 2.03). Relations between continuous variables were examined using the least-squares method of linear regression. P<0.05 was considered statistically significant.

	Results

Top Abstract Introduction Methods Results Discussion Conclusions References

 
IJV Blood Flow and Its Origin
In the control and CHF groups, 6 of 8 patients had right and 2 of 8 subjects had left cortical drainage, respectively. Internal jugular blood flows were not significantly different between the 2 groups (CHF: cortical, 405±80 mL/min; subcortical, 318±115 mL/min; controls: cortical, 436±60 mL/min; subcortical 284±40 mL/min).

Central Noradrenergic Activity
As presented in Figure 1, suprabulbar subcortical NE turnover was greater in CHF patients than in the control group (2.77±0.75 versus 0.66±0.40 nmol/min; P<0.05). When examining the relationship between cortical and subcortical noradrenergic activity, there was evidence of a significant increase in suprabulbar subcortical noradrenergic activity in CHF (0.64±0.59 versus 2.77±0.75 nmol/min for cortical versus subcortical flow; P<0.05). This relationship did not exist in the control group (1.37±0.54 versus 0.66±0.40 nmol/min for cortical versus subcortical flow; P=NS).

Relationship Between Brain NE Turnover and Peripheral Sympathetic Activity
As presented in Figure 2, when data from the subcortical vein in all 16 subjects was analyzed, a significant positive correlation was observed between total body NE spillover and suprabulbar subcortical NE turnover (y=2.12+0.47x; r=0.62, P=0.01).

View larger version (12K): [in this window] [in a new window]   Figure 2. Correlation between subcortical internal jugular venous NE spillover and total-body NE spillover in all subjects.

Hemodynamic Correlates of Sympathetic Activity
Data are available from 8 patients to study the relationship between cardiac filling pressures and central noradrenergic activity. No significant correlation was observed between pulmonary capillary wedge pressure and brain NE turnover in either the cortical or suprabulbar subcortical areas.

	Discussion

Top Abstract Introduction Methods Results Discussion Conclusions References

 
Although the pathophysiological role of the sympathetic nervous system in CHF is widely accepted,^1–3 an understanding of the mechanisms responsible for the heightened sympathetic drive remains elusive. Identifying these mechanisms may allow for early therapeutic intervention and ensuing clinical benefit.

Using methodologies such as the retrograde transsynaptic transport of live pseudorabies virus,¹⁰ a substantial body of evidence now exists from animal studies showing that groups of NE-releasing neurons in the brain stem and forebrain, assorted into nuclei designated A1 to A7, innervate all levels of sympathetic nervous outflow.¹¹ In humans, techniques to examine central sympathetic function are limited to measuring the overflow of NE and its metabolites from the brain.¹² After the demonstration by Maas et al¹² that central nervous system neuronal activity of stump-tailed monkeys could be studied by direct IJV blood sampling for MHPG, the major central nervous system metabolite of NE, this technique has been applied to humans.^4–6 At present, it is the "gold standard" for measuring central noradrenergic activity.

In the present study, NE turnover was increased in the supra-bulbar subcortical areas in CHF patients when compared with a healthy, age-matched control group. Furthermore, subcortical NE turnover was significantly greater than in the cortex in CHF, but this differentiation did not exist in the control subjects. In addition, there was a strong positive correlation between suprabulbar subcortical NE turnover and global sympathetic activity.

In the present study, we were unable to demonstrate a correlation between cardiac filling pressures and suprabulbar subcortical brain NE turnover. This was somewhat surprising given the earlier observation in the rat that cardiopulmonary volume afferents project to the noradrenergic nuclei of the locus ceruleus (A6) and the firing rate of locus ceruleus neurons is changed by alterations in cardiopulmonary pressures.¹³ There are 2 possible explanations for this observed lack of correlation. First, CHF therapy may distort any relationship that may exist between filling pressures and central monoamine turnover. Second, the sympathetic nervous stimulation in CHF may result from a state of desensitization of low-pressure baroreflexes, thereby forming a basis for withdrawal of tonic inhibition of peripheral sympathetic activity.¹⁴

	Conclusions

Top Abstract Introduction Methods Results Discussion Conclusions References

 
This study examines the central origins and regulatory mechanisms underlying the heightened sympathetic drive in human heart failure. We have shown that neuronal NE turnover in suprabulbar subcortical regions of the brain is increased and positively correlated with the level of whole-body NE spillover in human CHF. The findings support the hypothesis that the activation of noradrenergic neurons projecting rostrally from the brain stem mediates the sympathetic nervous stimulation present in CHF.

	Acknowledgments

 
Dr Aggarwal is a recipient of a Postgraduate Medical Research Scholarship from the National Health and Medical Research Council of Australia. Dr Kaye is the recipient of a Wellcome Trust Senior Research Fellowship. The authors thank Drs Michael Kelly and Victor Kalff of the Alfred Hospital Nuclear Medicine Department.

Received November 26, 2001; revision received January 10, 2002; accepted January 12, 2002.

	References

Top Abstract Introduction Methods Results Discussion Conclusions References

 
1. Kaye DM, Lefkovits J, Jennings GL, et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995; 26: 1257–1263.[Abstract]

2. Meredith IT, Broughton A, Jennings GL, et al. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med. 1991; 325: 618–624.[Abstract]

3. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984; 311: 819–823.[Abstract]

4. Ferrier C, Jennings GL, Eisenhofer G, et al. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens. 1993; 11: 1217–1227.[Medline] [Order article via Infotrieve]

5. Kaye DM, Lambert GW, Lefkovits J, et al. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994; 23: 570–578.[Abstract]

6. Lambert GW, Kaye DM, Lefkovits J, et al. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation. 1995; 92: 1813–1818.[Abstract/Free Full Text]

7. Gray H. Gray’s Anatomy. 36th ed. Edinburgh: Churchill Livingstone; 1980.

8. Esler M, Jennings G, Lambert G, et al. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990; 70: 963–985.[Free Full Text]

9. Eisenhofer G, Goldstein DS, Stull R, et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem. 1986; 32: 2030–2033.[Abstract/Free Full Text]

10. Strack AM, Sawyer WB, Hughes JH, et al. A general pattern of CNS innervation of the sympathetic outflow demonstrated by transneuronal pseudorabies viral infections. Brain Res. 1989; 491: 156–162.[CrossRef][Medline] [Order article via Infotrieve]

11. Hokfelt T, Johansson O, Goldstein M. Chemical anatomy of the brain. Science. 1984; 225: 1326–1334.[Abstract]

12. Maas JW, Hattox SE, Landis DH, et al. A direct method for studying 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) production by brain in awake animals. Eur J Pharmacol. 1977; 46: 221–228.[CrossRef][Medline] [Order article via Infotrieve]

13. Elam M, Yao T, Svensson TH, et al. Regulation of locus ceruleus neurons and splanchnic, sympathetic nerves by cardiovascular afferents. Brain Res. 1984; 290: 281–287.[CrossRef][Medline] [Order article via Infotrieve]

14. Thames MD, Kinugawa T, Smith ML, et al. Abnormalities of baroreflex control in heart failure. J Am Coll Cardiol. 1993; 22: 56A–60A.

This article has been cited by other articles:

				I. H. Zucker, H. D. Schultz, K. P. Patel, W. Wang, and L. Gao Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1557 - H1566. [Abstract] [Full Text] [PDF]

				J. S. Floras Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 375 - 385. [Abstract] [Full Text] [PDF]

				S. Kasparov and A. G. Teschemacher Altered central catecholaminergic transmission and cardiovascular disease Exp Physiol, June 1, 2008; 93(6): 725 - 740. [Abstract] [Full Text] [PDF]

				I. H. Zucker Novel Mechanisms of Sympathetic Regulation in Chronic Heart Failure Hypertension, December 1, 2006; 48(6): 1005 - 1011. [Full Text] [PDF]

				M. Arzt, T. Young, L. Finn, J. B. Skatrud, C. M. Ryan, G. E. Newton, S. Mak, J. D. Parker, J. S. Floras, and T. D. Bradley Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med, September 18, 2006; 166(16): 1716 - 1722. [Abstract] [Full Text] [PDF]

				G. Lambert, M. Elam, P. Friberg, C. Lundborg, S. Gao, J. Bergquist, and P. Nitescu Acute response to intracisternal bupivacaine in patients with refractory pain of the head and neck J. Physiol., January 15, 2006; 570(2): 421 - 428. [Abstract] [Full Text] [PDF]

				J. Spaak, Z. J. Egri, T. Kubo, E. Yu, S.-I. Ando, Y. Kaneko, K. Usui, T. D. Bradley, and J. S. Floras Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep Apnea Hypertension, December 1, 2005; 46(6): 1327 - 1332. [Abstract] [Full Text] [PDF]

				P. W. Gold, M.-L. Wong, D. S. Goldstein, H. K. Gold, D. S. Ronsaville, M. Esler, S. Alesci, A. Masood, J. Licinio, T. D. Geracioti Jr., et al. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia PNAS, June 7, 2005; 102(23): 8303 - 8308. [Abstract] [Full Text] [PDF]

				D. Kaye and M. Esler Sympathetic neuronal regulation of the heart in aging and heart failure Cardiovasc Res, May 1, 2005; 66(2): 256 - 264. [Abstract] [Full Text] [PDF]

				S. Vincent, P. R. Bieck, E. M. Garland, C. Loghin, F. P. Bymaster, B. K. Black, C. Gonzales, W. Z. Potter, and D. Robertson Clinical Assessment of Norepinephrine Transporter Blockade Through Biochemical and Pharmacological Profiles Circulation, June 29, 2004; 109(25): 3202 - 3207. [Abstract] [Full Text] [PDF]

				M. Esler and D. Kaye Is Very High Sympathetic Tone in Heart Failure a Result of Keeping Bad Company? Hypertension, November 1, 2003; 42(5): 870 - 872. [Full Text] [PDF]

				R. U. Pliquett, K. G. Cornish, J. D. Peuler, and I. H. Zucker Simvastatin Normalizes Autonomic Neural Control in Experimental Heart Failure Circulation, May 20, 2003; 107(19): 2493 - 2498. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aggarwal, A. Articles by Kaye, D. M. Search for Related Content PubMed PubMed Citation Articles by Aggarwal, A. Articles by Kaye, D. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure Related Collections Cardio-renal physiology/pathophysiology